Antibody response to insulin in children and adolescents with newly diagnosed Type 1 diabetes

Diabetic Medicine

Volumn 25, Issue 7, 2008, Pages 792-797

  Holmberg, H ^b   Mersebach, H ^b   Kanc, K ^b   Ludvigsson, J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Adolescent diabetes; Antibodies; Childhood diabetes; Insulin aspart; Insulin autoantibodies

Indexed keywords

CROSS REACTING ANTIBODY; HEMOGLOBIN A1C; INSULIN ANTIBODY; INSULIN ASPART; ISOPHANE INSULIN; NEUTRAL INSULIN; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN; INSULIN, ASP(B28)-;

ADOLESCENT; ALCOHOL INTOXICATION; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; GLYCEMIC CONTROL; GROUPS BY AGE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KETOACIDOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; RADIOIMMUNOASSAY; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT RESPONSE; ANTIBODY PRODUCTION; CASE CONTROL STUDY; COMPARATIVE STUDY; IMMUNOLOGY; METABOLISM; TREATMENT OUTCOME;

ADOLESCENT; ANTIBODY FORMATION; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN ANTIBODIES; INSULIN, ISOPHANE; MALE; TREATMENT OUTCOME;

EID: 49649097158     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02468.x     Document Type: Article

References (15)

1. Falorni A, Brozzetti A. Diabetes-related antibodies in adult diabetic patients. Best Pract Res Clin Endocrinol Metab 2005; 19: 119-133.
2. Bingley PJ, Bonifacio E, Mueller PW. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 2003; 52: 1128-1136.
3. Schernthaner G. Immunogenicity and allergenic potential of animal and human insulins. Diabetes Care 1993; 16 (Suppl. 3): 155-165.
4. Marshall MO, Heding LG, Villumsen J, Akerblom HK, Baevre H, Dahlquist G et al. Development of insulin antibodies, metabolic control and B-cell function in newly diagnosed insulin dependent diabetic children treated with monocomponent human insulin or monocomponent porcine insulin. Diabetes Res 1988; 9: 169-175.
5. Lindholm A, Jensen LB, Home PD, Raskin P, Boehm BO, Rastam J. Immune responses to insulin aspart and biphasic insulin aspart in people with Type 1 and Type 2 diabetes. Diabetes Care2002; 25: 876-882.
6. Fineberg SE, Huang J, Brunelle R, Gulliya KS, Anderson JH, Jr. Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with Type 1 or Type 2 diabetes. Diabetes Care 2003; 26: 89-96.
7. Lindholm A, McEwen J, Riis AP. Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in Type 1 diabetes. Diabetes Care 1999; 22: 801-805.
8. Kang S, Creagh FM, Peters JR, Brange J, Volund A, Owens DR. Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in Type I diabetic subjects. Diabetes Care 1991; 14: 571-577.
9. Mortensen HB, Lindholm A, Olsen BS, Hylleberg B. Rapid appearance and onset of action of insulin aspart in paediatric subjects with Type 1 diabetes. Eur J Pediatr 2000; 159: 483-488.
10. NovoRapid®. Summary of Product Characteristics. Dec 2006. Available at http://www.emea.europa.eu/humandocs/PDFs/EPAR/ Novorapid/H-258-PI-en.pdf Last accessed 1 June 2007.
11. Kullberg C, Bergstrom A, Dinesen B, Larsson L, Little R, Goldstein D et al. Comparisons of studies on diabetic complications hampered by differences in GHb measurements. Diabetes Care 1996; 19: 726-729.
12. Karjalainen J, Knip M, Mustonen A, Åkerblom HK. Insulin autoantibodies at the clinical manifestation of Type 1 (insulin-dependent) diabetes-a poor predictor of clinical course and antibody response to exogenous insulin. Diabetologia 1988; 31: 129-133.
13. Sochett E, Daneman D. Relationship of insulin autoantibodies to presentation and early course of IDDM in children. Diabetes Care 1989; 12: 517-523.
14. Samuelsson U, Stenhammar L. Clinical characteristics at onset of Type 1 diabetes in children diagnosed between 1977 and 2001 in the south-east region of Sweden. Diabetes Res Clin Pract 2005; 68: 49-55.
15. Chen JW, Frystyk J, Lauritzen T, Christiansen JS. Impact of insulin antibodies on insulin aspart pharmacokinetics and pharmacodynamics after 12-week treatment with multiple daily injections of biphasic insulin aspart 30 in patients with Type 1 diabetes. Eur J Endocrinol 2005; 153: 907-913.